搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
5 小时
Pancreatic Cancer Treatment Market Size, Trends Analysis ad Segment Forecasts 2025-2030
The "Pancreatic Cancer Treatment Market Size, Share & Trends Analysis By Type, By Treatment, By Distribution Channel, By ...
labiotech
8 天
Pancreatic cancer: Oncolytics Biotech, Candel, and CytomX bring promising therapies to the ...
Discover new treatments currently being developed for pancreatic cancer, which has historically been extremely difficult to ...
1 天
RenovoRx: From Clinical Promise To Commercial Reality And Trading At A Significant Discount
RenovoRx's innovative RenovoCath and TAMP platform show promising clinical data. Click here to read why RNXT stock presents ...
Medpage Today on MSN
11 天
Geriatric Assessment, QoL Correlate With OS in Older Patients With Pancreatic Cancer
SAN FRANCISCO -- Older patients' survival in metastatic pancreatic cancer had a significant association with baseline ...
Medscape
8 天
Novel Anti-CTGF Antibody Plus Chemotherapy Shows No Survival Benefit in Locally Advanced ...
Adding pamrevlumab to standard chemotherapy did not improve survival in patients with locally advanced pancreatic cancer ...
6 天
Elicio: Lymph Node Binding With ELI-002 Could Lead To Substantial 1st Half 2025 Data
Elicio Therapeutics aims for breakthrough treatment with ELI-002 in pancreatic cancer. Find out why ELTX stock may benefit ...
조선일보
13 天
Korea approves clinical trial for advanced pancreatic cancer chemotherapy
and patients with advanced pancreatic cancer, who have a high recurrence rate, are now able to experience a new treatment method that selectively eliminates cancer cells. The 5-year relative survival ...
Targeted Oncology
8 天
Spira on ctDNA in KRAS G12D Pancreatic Cancer and Zoldonrasib
Alexander I. Spira, MD, PhD, FACP, discusses the clinical implications of ctDNA for treatment decisions and monitoring in ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈